Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,495,922 papers from all fields of science
Search
Sign In
Create Free Account
Deny (action)
Known as:
Denial
, Reject
, Rejection
Expand
Refuse to accept, recognize or acknowledge.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Broadband quasi-Chebyshev bandpass filters with multimode stepped-impedance resonators (SIRs)
Y. Chiou
,
J. Kuo
,
E. Cheng
IEEE transactions on microwave theory and…
2006
Corpus ID: 17516440
Planar broadband bandpass filters of order up to 9 are synthesized based on the multimode property of stepped-impedance…
Expand
Highly Cited
2002
Highly Cited
2002
Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts1
S. Sumitran‐Holgersson
,
H. Wilczek
,
J. Holgersson
,
Kalle Söderström
Transplantation
2002
Corpus ID: 22330804
Background. A substantial portion of kidney allografted patients experience early acute rejection episodes and even irreversible…
Expand
Highly Cited
2000
Highly Cited
2000
Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.
Christene A. Huang
,
Y. Fuchimoto
,
R. Scheier-Dolberg
,
M. Murphy
,
D. Neville
,
D. Sachs
Journal of Clinical Investigation
2000
Corpus ID: 24687672
Bone marrow transplantation (BMT) has considerable potential for the treatment of malignancies, hemoglobinopathies, and…
Expand
Highly Cited
2000
Highly Cited
2000
CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft Rejection1
N. Jones
,
A. van Maurik
,
+4 authors
K. Wood
Journal of Immunology
2000
Corpus ID: 45999117
In experimental transplantation, blockade of CD40-CD40 ligand (CD40L) interactions has proved effective at permitting long-term…
Expand
Highly Cited
1996
Highly Cited
1996
Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.
Abrar Khan
,
Y. Tomita
,
M. Sykes
Transplantation
1996
Corpus ID: 8756605
A nonmyeloablative conditioning regimen has recently been developed that allows allogeneic marrow engraftment with induction of…
Expand
Highly Cited
1995
Highly Cited
1995
Bayesian Learning for Neural Networks
Radford M. Neal
1995
Corpus ID: 60809283
Artificial "neural networks" are widely used as flexible models for classification and regression applications, but questions…
Expand
Highly Cited
1995
Highly Cited
1995
Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein
I. Hara
,
Y. Takechi
,
A. Houghton
Journal of Experimental Medicine
1995
Corpus ID: 14377470
The immune system can recognize differentiation antigens that are selectively expressed on malignant cells and their normal cell…
Expand
Highly Cited
1995
Highly Cited
1995
A reassessment of the role of B7-1 expression in tumor rejection
T. Wu
,
Alex Y.C. Huang
,
Elizabeth M. Jaffee
,
H. Levitsky
,
D. Pardoll
Journal of Experimental Medicine
1995
Corpus ID: 1073692
Introduction of the B7-1 gene into murine tumor cells can result in rejection of the B7-1 transductants and, in some cases…
Expand
Highly Cited
1982
Highly Cited
1982
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients
R. Storb
,
K. Doney
,
+11 authors
R. Witherspoon
1982
Corpus ID: 216037841
Sixty-five multiply transfused patients with severe aplastic anemia were given cyclophosphamide followed by grafts anemia were…
Expand
Review
1956
Review
1956
Some recent work on tumor immunity.
P. Gorer
Advances in Cancer Research
1956
Corpus ID: 5206662
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE